Operating Expenses 변화 날짜
AbbVie USD 11.11B 540M 2023-12
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Acorda Therapeutics USD 33.31M 427K 2023-06
ALKERMES USD 337.09M 41.11M 2023-09
Amgen USD 6.93B 2.11B 2023-12
Biogen USD 2.03B 344.1M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
Heron Therapeutics USD 56.36M 17.8M 2023-09
Intra Cellular Therapies USD 166.2M 10.31M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
J&J USD 16.57B 435M 2023-12
Malin Corporation EUR 2.2M 800K 2023-06
Marinus Pharmaceuticals USD 38.98M 1.46M 2023-09
Merck USD 16.56B 6.35B 2023-12
Minerva Neurosciences USD 6.08M 1.56M 2023-09
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Otsuka Holdings JPY 459.58B 14.3B 2023-09
Ovoca Bio EUR 5.65M 3.45M 2022-06
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Revance Therapeutics USD 196.07M 72.44M 2023-09
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



ALKERMES 운영 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2024.